Clinical trials
Fistula trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 3 |
| Central Hospital, Nancy, France | 2 |
| University of Calgary | 2 |
| Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University | 1 |
| American Access Care | 1 |
| Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Cellerix | 1 |
| E. Peden, MD | 1 |
| French Society of Coloproctology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fistula | 32 |
| Crohn Disease | 7 |
| Rectal Fistula | 4 |
| Abscess | 2 |
| Hypospadias | 2 |
| Renal Insufficiency | 2 |
| Renal Insufficiency, Chronic | 2 |
| Carcinoma, Adenoid Cystic | 1 |
| Carcinoma, Mucoepidermoid | 1 |
| Carcinoma, Squamous Cell | 1 |
Trials
Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.